13087 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Levine
    Levine
  4. Zelenetz
    Zelenetz
  5. Horwitz
    Horwitz
  6. Abdel-Wahab
    Abdel-Wahab
  7. Scheinberg
    Scheinberg
  8. Jakubowski
    Jakubowski
  9. Landau
    Landau
  10. Shah
    Shah

Groups

  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)
  7. Lymphoma (2639)
  8. Sloan Kettering Institute Faculty (2602)
  9. Executive Committee, Center for Hematologic Malignancies (2358)
  10. Survivorship Research (2328)
  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeted deep sequencing in untreated progressive CLL helps to better dissect the genomic landscape and shows novel associations between mutations, prognostic and clinical parameters: Data from E1912, a randomized phase III study of the ECOG-ACRIN cancer research group
    Meeting Abstract

    Braggio, E.; Wang, V.; Bruins, L. A.; Barrio, S.; Lesnick, C.; Barrientos, J. C.; O'Brien, S. M.; Tallman, M. S.; Litzow, M. R.; Fonseca, R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Efficacy of donor lymphocyte infusion in CD34+ selected allogeneic hematopoietic stem cell transplant for myeloid and lymphoid malignancies: A single center experience
    Meeting Abstract

    Bryant, A.; Devlin, S. M.; Castro-Malaspina, H. R.; Jakubowski, A. A.; Maloy, M.; Papadopoulos, E. B.; Giralt, S. A.; Perales, M. A.
    Blood (2017)

    Fulltext@MSK | Save
  • Changes in RT-qPCR levels during and after TKI interruptions for attempted conceptions in women with CML
    Meeting Abstract

    Caldwell, L.; Claudiani, S.; Milojkovic, D.; Szydlo, R.; Abruzzese, E.; Nesr, G.; Mauro, M. J.; Palanicawander, R.; Gatenby, A.; Sabli, I.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • The effect of conditioning regimen dose reduction in obese patients undergoing autologous transplantation
    Meeting Abstract

    Brunstein, C. G.; Pasquini, M. C.; Kim, S.; Fei, M.; Artz, A.; Battiwalla, M.; Bejanyan, N.; Gale, R. P.; Hematti, P.; Lahoud, O. B.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Risk factors for grade 3/4 transaminase elevation in patients with chronic lymphocytic leukemia treated with idelalisib
    Meeting Abstract

    Brown, J. R.; Zelenetz, A. D.; Furman, R. R.; Lamanna, N.; Mato, A. R.; Montillo, M.; O'Brien, S. M.; Dreiling, L. K.; Dubowy, R. L.; Kim, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Integrated molecular analysis identifies replicative stress as sensitizer to imetelstat therapy in AML
    Meeting Abstract

    Bruedigam, C.; Porter, A. H.; Wackrow, B.; Straube, J.; Cooper, L. T.; Song, A.; Lee, S. C. W.; Abdel-Wahab, O.; Hill, G. R.; Lane, S. W.
    Blood (2017)

    Fulltext@MSK | Save
  • Safety and efficacy trial of escalation of plerixafor for mobilization of CD34+ hematopoietic progenitor cells (HPCs) for globin gene transfer in patients with sickle cell disease
    Meeting Abstract

    Boulad, F.; Shore, T. B.; Van Besien, K.; Guarneri, D.; Greenberg, J.; Minniti, C.; Wiener Fedus, S.; Perna, F.; Wang, X.; Riviere, I.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Active surveillance for newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma
    Meeting Abstract

    Borchmann, S.; Joffe, E.; Moskowitz, C. H.; Zelenetz, A. D.; Noy, A.; Portlock, C. S.; Gerecitano, J. F.; Batlevi, C.; Caron, P.; Drullinsky, P.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • National survey demonstrates practice gaps in cytogenetic and molecular testing in acute myeloid leukemia
    Meeting Abstract

    Altman, J. K.; Denzen, E.; Block, A. W.; Hasserjian, R. P.; Klepin, H.; Medeiros, B. C.; Noe, A.; Scales, W. E.; Tallman, M. S.; Wiley, K.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • TTI-621 (SIRPαFc), an immune checkpoint inhibitor blocking the CD47 "do not eat" signal, induces objective responses in patients with advanced, relapsed/refractory diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Ansell, S. M.; Flinn, I. W.; Maris, M. B.; O'Connor, O. A.; Lesokhin, A.; Advani, A. S.; Minden, M. D.; Percival, M. B. M.; Johnson, L. D. S.; Catalano, T.; more...
    Blood (2017)

    Fulltext@MSK | Save